NSE ScannerPharmaceuticals · Pharmaceuticals: Major · NSE: PGHL · data 2026-10-30
Procter & Gamble Health Ltd.
In plain words
Price: 18.7% below its 52-week high of ₹6,975.
Delivery: 57.2% of traded shares were kept for delivery over the last 10 sessions, against 56.0% over the last 60.
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹1,408 cr |
| Net profit (last 12 months) | ₹327 cr |
| Sales growth, 3 years (yearly) | 8.2% |
| Profit growth, 3 years (yearly) | 19.3% |
Smart-money activity
20/100 · Weak over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 7/30: Delivery 58.6% over the last 20 sessions vs 47.4% in the 40 before (1.24x); shares delivered per day 0.8x usual; 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 8/15: Verdict "Building", sustained score 45/100.
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Dividend
- 27 Aug 26Dividend Dividend ₹45 (ex-date) -1.7% next session
- 12 Feb 26Dividend Dividend ₹110 (ex-date) -9.0% next session
- 22 Aug 25Dividend Dividend ₹45 (ex-date) +1.2% next session
- 21 Feb 25Dividend Dividend ₹80 (ex-date) -3.3% next session
- 28 Nov 24Dividend Dividend ₹60 (ex-date) -0.6% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Common questions
Is Procter & Gamble Health Ltd. debt-free?
Its latest reported debt-to-equity ratio is 0.02, which is very low.
What is Procter & Gamble Health Ltd.'s P/E ratio?
About 28.8, based on the last 12 months' earnings and a price of ₹5,670.5 (data 2026-10-30).
What is the 52-week high and low of Procter & Gamble Health Ltd.?
The 52-week high is ₹6,975 and the 52-week low is ₹4,707.
Mutual funds holding Procter & Gamble Health Ltd.
From the monthly portfolios of the fund houses the site reads, as of 2026-09-30. 4 schemes holding about ₹113 cr; funds that hold it outside their top holdings may not be listed.
| Scheme | Fund house | % of fund | Value |
|---|---|---|---|
| ADITYA BIRLA SUN LIFE MNC FUND | Aditya Birla Sun Life Mutual Fund | 1.74% | ₹53 cr |
| ADITYA BIRLA SUN LIFE CONSUMPTION FUND | Aditya Birla Sun Life Mutual Fund | 0.43% | ₹25 cr |
| ADITYA BIRLA SUN LIFE PHARMA & HEALTHCARE FUND | Aditya Birla Sun Life Mutual Fund | 1.82% | ₹20 cr |
| ADITYA BIRLA SUN LIFE BUSINESS CYCLE FUND | Aditya Birla Sun Life Mutual Fund | 0.92% | ₹16 cr |
Similar companies
Strides Pharma Science Ltd (STAR) · Viyash Scientific Limited (VIYASH) · Blue Jet Healthcare Limited (BLUEJET) · Aarti Pharmalabs Limited (AARTIPHARM) · Symbiotec Pharmalab Limited (SYMBIOTEC)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open PGHL in NSE Scanner →